Cargando…
The rationale for using low-molecular weight heparin in the therapy of symptomatic COVID-19 patients
Accumulated evidence suggest that the adverse outcome of severe coronavirus disease 2019 (COVID-19) is closely related to prothrombotic microvascular pathology with a high risk of venous thromboembolism. Furthermore, the first observational studies indicated that adjunct therapy with low-molecular w...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
De Gruyter
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812716/ https://www.ncbi.nlm.nih.gov/pubmed/35178474 http://dx.doi.org/10.1515/med-2021-0374 |